TABLE 1. IGG SUBCLASS
TABLE 2. FREQUENCY (%) OF DECREASED IGG SUBCLASS CONCENTRATION IN ADULTS
TABLE 3. DISEASES ASSOCIATED WITH IGG SUBCLASS DEFICIENCY
TABLE 4. MALAYSIA IVIG MARKET, BY APPLICATION, 2014-2022 ($THOUSAND)
TABLE 5. MALAYSIA IVIG MARKET, BY APPLICATION, 2014-2022 (KILOGRAM)
TABLE 6. COMMON MEDICATION FOR THE HYPOGAMMAGLOBULINEMIA ASSOCIATED WITH RECURRENT BACTERIAL INFECTIONS
TABLE 7. MALAYSIA IVIG MARKET FOR HYPOGAMMAGLOBULINEMIA APPLICATION, 2014-2022 ($THOUSAND AND KILOGRAM)
TABLE 8. MALAYSIA IVIG MARKET FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY APPLICATION, 2014-2022 ($THOUSAND & KILOGRAM)
TABLE 9. PRINCIPLE OF IVIG THERAPY IN IMMUNODEFICIENCY
TABLE 10. MALAYSIA IVIG MARKET FOR PRIMARY IMMUNODEFICIENCY DISEASE APPLICATION, 2014-2022 ($THOUSAND & KILOGRAM)
TABLE 11. MALAYSIA IVIG MARKET FOR MYASTHENIA GRAVIS APPLICATION, 2014-2022 ($THOUSAND AND KILOGRAM)
TABLE 12. MALAYSIA IVIG MARKET FOR MULTIFOCAL MOTOR NEUROPATHY APPLICATION, 2014-2022 ($THOUSAND & KILOGRAM)
TABLE 13. MALAYSIA IVIG MARKET FOR PRIMARY IMMUNE THROMBOCYTOPENIC PURPURA APPLICATION, 2014-2022 ($THOUSAND & KILOGRAM)
TABLE 14. MALAYSIA IVIG MARKET FOR INFLAMMATORY MYOPATHY APPLICATION, 2014-2022 ($THOUSAND & KILOGRAM)
TABLE 15. MALAYSIA IVIG MARKET FOR SPECIFIC ANTIBODY DEFICIENCY APPLICATION, 2014-2022 ($THOUSAND & KILOGRAM)
TABLE 16. MALAYSIA IVIG MARKET FOR GUILLAIN-BARR SYNDROME APPLICATION, 2014-2022 ($THOUSAND & KILOGRAM)
TABLE 17. MALAYSIA IVIG MARKET FOR KAWASAKI DISEASE APPLICATION, 2014-2022 ($THOUSAND & KILOGRAM)
TABLE 18. IVIG MARKET FOR SECONDARY IMMUNODEFICIENCY APPLICATION, 2014-2022 ($THOUSAND & KILOGRAM)
TABLE 19. MALAYSIA IVIG MARKET FOR OTHER APPLICATIONS, 2014-2022 ($THOUSAND & KILOGRAM)
TABLE 20. MALAYSIA IVIG MARKET, BY MODE OF DELIVERY, 2014-2022 ($THOUSAND)
TABLE 21. MALAYSIA IVIG MARKET, BY MODE OF DELIVERY, 2014-2022 (KILOGRAM)
TABLE 22. MALAYSIA IVIG MARKET FOR INTRAVENOUS MODE OF DELIVERY, 2014-2022 ($THOUSAND & KILOGRAM)
TABLE 23. MALAYSIA IVIG MARKET FOR SUBCUTANEOUS MODE OF DELIVERY, 2014-2022 ($THOUSAND & KILOGRAM)
TABLE 24. MALAYSIA IVIG MARKET FOR INTRAMUSCULAR MODE OF DELIVERY, 2014-2022 ($THOUSAND & KILOGRAM)
TABLE 25. MALAYSIA IVIG MARKET, BY CONCENTRATION, 2014-2022 ($THOUSAND)
TABLE 26. MALAYSIA IVIG MARKET, BY CONCENTRATION, 2014-2022 (KILOGRAM)
TABLE 27. MALAYSIA IVIG MARKET FOR 5% CONCENTRATION, 2014-2022 ($THOUSAND & KILOGRAM)
TABLE 28. MALAYSIA IVIG MARKET FOR 10% CONCENTRATION, 2014-2022 ($THOUSAND & KILOGRAM)
TABLE 29. MALAYSIA IVIG MARKET FOR OTHER CONCENTRATIONS, 2014-2022 ($THOUSAND & KILOGRAM)
TABLE 30. BAXTER: COMPANY SNAPSHOT
TABLE 31. BAXTER: OPERATING SEGMENTS
TABLE 32. BAXTER: PRODUCT PORTFOLIO
TABLE 33. BAYER: COMPANY SNAPSHOT
TABLE 34. BAYER: OPERATING SEGMENTS
TABLE 35. BAYER: PRODUCT PORTFOLIO
TABLE 36. BIOTEST: COMPANY SNAPSHOT
TABLE 37. BIOTEST: OPERATING SEGMENTS
TABLE 38. BIOTEST: PRODUCT PORTFOLIO
TABLE 39. CSL: COMPANY SNAPSHOT
TABLE 40. CSL: OPERATING SEGMENTS
TABLE 41. CSL: PRODUCT PORTFOLIO
TABLE 42. GREEN CROSS: COMPANY SNAPSHOT
TABLE 43. GREEN CROSS: OPERATING SEGMENTS
TABLE 44. GREEN CROSS: PRODUCT PORTFOLIO
TABLE 45. GRIFOLS: COMPANY SNAPSHOT
TABLE 46. GRIFOLS: OPERATING SEGMENTS
TABLE 47. GRIFOLS: PRODUCT PORTFOLIO
TABLE 48. J&J: COMPANY SNAPSHOT
TABLE 49. J&J: OPERATING SEGMENTS
TABLE 50. J&J: PRODUCT PORTFOLIO
TABLE 51. KEDRION: COMPANY SNAPSHOT
TABLE 52. KEDRION: OPERATING SEGMENTS
TABLE 53. KEDRION: PRODUCT PORTFOLIO
TABLE 54. OCTAPHARMA: COMPANY SNAPSHOT
TABLE 55. OCTAPHARMA: PRODUCTION AREAS
TABLE 56. OCTAPHARMA: PRODUCT PORTFOLIO
TABLE 57. SHIRE: COMPANY SNAPSHOT
TABLE 58. SHIRE: PRODUCT PORTFOLIO

LIST OF FIGURE

FIGURE 1. MARKET SEGMENTATION
FIGURE 2. PERCENTAGE SHARE OF COST ASSOCIATED WITH SIDE EFFECTS INDUCED BY IVIG THERAPY
FIGURE 3. TOP FACTORS IMPACTING MALAYSIA IVIG MARKET (2015-2021)
FIGURE 4. TOP INVESTMENT POCKETS
FIGURE 5. BARGAINING POWER OF BUYERS
FIGURE 6. BARGAINING POWER OF SUPPLIERS
FIGURE 7. THREAT OF NEW ENTRANTS
FIGURE 8. THREAT OF SUBSTITUTION
FIGURE 9. COMPETITIVE RIVALRY
FIGURE 10. VALUE CHAIN ANALYSIS OF MALAYSIA IVIG MARKET
FIGURE 11. BAXTER: NET SALES, 2014-2016 ($MILLION)
FIGURE 12. BAXTER: REVENUE BY PRODUCT, 2016 (%)
FIGURE 13. BAXTER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 14. BAYER: NET SALES, 2014-2016 ($MILLION)
FIGURE 15. BAYER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 16. BIOTEST: NET SALES, 2014-2016 ($MILLION)
FIGURE 17. BIOTEST: REVENUE BY SEGMENT, 2016 (%)
FIGURE 18. BIOTEST: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 19. CSL: NET SALES, 2014-2016 ($MILLION)
FIGURE 20. CSL: REVENUE BY PRODUCT, 2016 (%)
FIGURE 21. CSL: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 22. GREEN CROSS: NET SALES, 2014-2016 ($MILLION)
FIGURE 23. GREEN CROSS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 24. GREEN CROSS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 25. GRIFOLS: NET SALES, 2014-2016 ($MILLION)
FIGURE 26. GRIFOLS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 27. GRIFOLS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 28. J&J: NET SALES, 2014-2016 ($MILLION)
FIGURE 29. J&J: REVENUE BY SEGMENT, 2016 (%)
FIGURE 30. J&J: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 31. KEDRION: NET SALES, 2014-2016 ($MILLION)
FIGURE 32. OCTAPHARMA: NET SALES, 2014-2016 ($MILLION)
FIGURE 33. SHIRE: NET SALES, 2014-2016 ($MILLION)
FIGURE 34. SHIRE: REVENUE BY GEOGRAPHY, 2016 (%)